Coverage Update: Over 40 million more patients in and across the US have increased access to electron-based IORT for low risk breast cancer Throughout 2017, based on the growing body of evidence and the updated ASTRO Consensus Statement on APBI, affirming the efficacy of single-treatment electron IORT, many private insurance carriers have updated their medical policies … Continued
Read MoreMedia Inquiry
Kristi Taylor
ktaylor@intraop.com
+1 408.636.1020
Mail to:
125 Almaden Blvd
Suite 1250
San Jose, CA. 95113